1 results match your criteria: "USA. jberenson@berensoncancercenter.org.[Affiliation]"
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma.
Leukemia
December 2021
Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA.
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against SARS-CoV-2 is unknown. Thus, we analyzed responses to mRNA vaccination against COVID-19 among these patients.
View Article and Find Full Text PDF